Medicare would cover home treatment for Alpha-1 Antitrypsin Deficiency Disorder
Right now, Medicare Part B does not explicitly cover home treatment for Alpha-1 Antitrypsin Deficiency Disorder. This bill would change that, adding coverage for specific augmentation therapy, intravenous administration kits, and nursing care at home for eligible individuals. These changes would start on January 1, 2027.
Today, Medicare Part B does not explicitly cover home treatment for Alpha-1 Antitrypsin Deficiency Disorder. This includes specific augmentation therapy, intravenous administration kits, or associated nursing services. If this bill becomes law, Medicare Part B would cover these treatments and services for eligible individuals in their homes. It would pay 80% of the cost for kits and up to 2 hours of nursing care.
HR 2343 · 119th Congress · March 25, 2025 · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers
2 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.